Characterization of AZD8055, a potent selective inhibitor of mTORC1 and mTORC2 kinase

被引：0
|
作者：
Chresta, Christine
Davies, Barry
Harding, Tom
Hickson, Ian
Cosulich, Sabina
Critchlow, Susan
Sini, Patrizia
James, Dominic
Malagu, Karine
Hummersone, Marc
Smith, Graeme
Pass, Martin
Guichard, Sylvie
机构：
[1] AstraZeneca R&D, Macclesfield, Cheshire, England
[2] KuDOS Pharmaceut Ltd, Cambridge, England
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4770
引用
收藏
页数：2
相关论文
共 50 条
  • [31] REGULATION AND METABOLIC FUNCTIONS OF mTORC1 AND mTORC2
    Szwed, Angelia
    Kim, Eugene
    Jacinto, Estela
    [J]. PHYSIOLOGICAL REVIEWS, 2021, 101 (03) : 1371 - 1426
  • [32] mTORC1/mTORC2 SIGNALING IN PILOCYTIC ASTROCYTOMA
    Hutt, Marianne
    Karajannis, Matthias A.
    Shah, Smit
    Eberhart, Charles G.
    Raabe, Eric
    Rodriguez, Fausto J.
    [J]. NEURO-ONCOLOGY, 2013, 15 : 48 - 48
  • [33] Identification of clinical candidate, AZD8055: A potent, selective small molecule inhibitor of mTOR kinase
    Pike, Kurt G.
    Menear, Keith
    Gomez, Sylvie
    Malagu, Karine
    Hummersome, Marc
    Pass, Martin
    Duggan, Heather
    Hickson, Ian
    Chresta, Christine
    Davies, Barry
    Martin, Niall
    Smith, Graeme
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [34] Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
    Tang, Haiyang
    Wu, Kang
    Wang, Jian
    Vinjamuri, Sujana
    Gu, Yali
    Song, Shanshan
    Wang, Ziyi
    Zhang, Qian
    Balistrieri, Angela
    Ayon, Ramon J.
    Rischard, Franz
    Vanderpool, Rebecca
    Chen, Jiwang
    Zhou, Guofei
    Desai, Ankit A.
    Black, Stephen M.
    Garcia, Joe G. N.
    Yuan, Jason X-J
    Makino, Ayako
    [J]. JACC-BASIC TO TRANSLATIONAL SCIENCE, 2018, 3 (06): : 744 - 762
  • [35] The role of mTORC1 and mTORC2 in UVB-induced
    Lewis, Martha
    Shantz, Lisa
    [J]. FASEB JOURNAL, 2013, 27
  • [36] mTORC1 and mTORC2 as regulators of cell metabolism in immunity
    Linke, Monika
    Fritsch, Stephanie Deborah
    Sukhbaatar, Nyamdelger
    Hengstschlaeger, Markus
    Weichhart, Thomas
    [J]. FEBS LETTERS, 2017, 591 (19): : 3089 - 3103
  • [37] Cellular characterization of OXA-01, a potent and selective dual mTORC1 and mTCRC2 kinase inhibitor
    Bhagwat, S. V.
    Crew, A. P.
    Gokhale, P. C.
    Cooke, A.
    Kahler, J.
    Yao, Y.
    Chan, A.
    Arnold, L. D.
    Wild, R.
    Pachter, J. A.
    [J]. EJC SUPPLEMENTS, 2008, 6 (12): : 102 - 102
  • [38] HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitor
    English, Diana P.
    Roque, Dana M.
    Carrara, Luisa
    Lopez, Salvatore
    Bellone, Stefania
    Cocco, Emiliano
    Bortolomai, Ileana
    Schwartz, Peter E.
    Rutherford, Thomas
    Santin, Alessandro D.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 131 (03) : 753 - 758
  • [39] First-in-human phase I trial of the dual mTORC1 and mTORC2 inhibitor AZD2014 in solid tumors
    Banerji, Udai
    Dean, Emma Jane
    Gonzalez, Michael
    Greystoke, Alastair P.
    Basu, Bristi
    Krebs, Matthew
    Puglisi, Martina
    Grinsted, Lynda
    Oelmann, Elisabeth
    Burke, Wendy
    Harrington, Elizabeth
    Green, Stephen
    Ranson, Malcolm
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
    Greg M Delgoffe
    Kristen N Pollizzi
    Adam T Waickman
    Emily Heikamp
    David J Meyers
    Maureen R Horton
    Bo Xiao
    Paul F Worley
    Jonathan D Powell
    [J]. Nature Immunology, 2011, 12 : 295 - 303
12345